Total planned funding: $204,095,873
Allocations
Countries/Regions
Eswatini | $204,095,873 |
Organizational Types
Private Contractor | $56,167,774 |
University | $44,715,490 |
NGO | $40,324,599 |
Own Agency | $25,627,515 |
Unknown | $20,112,080 |
Host Country Government Agency | $9,173,308 |
FBO | $6,188,454 |
Multi-lateral Agency | $1,073,840 |
Other USG Agency | $712,813 |
Program Areas
Care | $68,583,878 |
Treatment | $40,830,097 |
Prevention | $35,704,332 |
Governance and Systems | $25,250,405 |
Testing | $18,807,058 |
Management and Operations | $14,920,103 |
Budget Codes
HTXS: Treatment: Adult Treatment | $32,965,388 |
HBHC: Care: Adult Care and Support | $31,514,947 |
HKID: Care: Orphans and Vulnerable Children | $19,280,895 |
HVCT: Testing: HIV Testing and Counseling | $18,807,058 |
HVMS: Management and Operations | $14,920,103 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,647,912 |
HVTB: Care: TB/HIV | $12,468,229 |
OHSS: Health Systems Strengthening | $10,836,980 |
HVSI: Strategic Information | $9,733,999 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,895,066 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,798,487 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,500,867 |
PDCS: Care: Pediatric Care and Support | $5,319,807 |
HLAB: Laboratory Infrastructure | $4,679,426 |
PDTX: Treatment: Pediatric Treatment | $3,943,090 |
HTXD: Treatment: ARV Drugs | $3,921,619 |
HMBL: Biomedical Prevention: Blood Safety | $862,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$37,852,955
Countries/Regions
Pact, Inc.:
$24,595,982
Countries/Regions
Not Available:
$15,713,094
Countries/Regions
USG Aggregated Agencies:
$12,416,763
Countries/Regions